Answers are grounded in this paper and cite their sources.
‐lowering agents for treating pre‐existing and‐onset diabetes in kidney transplant recipients
No takes yet. Share an insight, caveat, or question.
Lo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: